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Background
Hypertrophic cardiomyopathy (HCM) is a genetic heart
disease characterized by diffuse histopathologic abnorm-
alities involving the entire LV myocardium, including an
expanded extracellular matrix due to replacement and
interstitial fibrosis and myocyte disarray. T1 mapping is
a novel CMR imaging sequence which characterizes
abnormal myocardial tissue composition in cardiomyo-
pathies such as HCM. Therefore, we sought to examine
the relationship between T1 values and a variety of
relevant demographic, clinical and imaging variables in
a cohort of HCM patients.
Methods
CMR imaging with late gadolinium enhancement and T1
mapping using a noncontrast Shortened Modified Look-
Locker Inversion recovery (ShMOLLI) method was per-
formed in 15 HCM patients (56±16 years; 80% male). After
obtaining a left ventricular short-axis stack with complete
ventricular coverage, T1 values were calculated for each
slice and a mean T1 value for the entire myocardium was
obtained. T1 values were then compared to a number of
relevant demographic, imaging and clinical variables.
Results
The mean T1 value of the global LV myocardium was 860
± 54 ms (range 768-977 ms). There was no relationship
between global T1 values and a number of relevant HCM
variables including: age (p= 0.43), maximal LV wall thick-
ness (p=0.35), LV mass index (p=0.50), presence or extent
of LGE (p= 0.07 and 0.50, respectively), heart failure symp-
toms (874 ms in NYHA class I vs. 860 ms NYHA class
II-IV; p=0.62), or between patients with or without resting
LV outflow tract obstruction (853 vs 878 ms; p=0.38).
Even when comparing mean T1 values of one mid-LV or
basal short-axis slice, no significant relationship was
present between these HCM variables (p>0.05 for mid and
basal slices).
With respect to clinical markers of increased risk, T1
values were not significantly different among HCM
patients with markedly increased LV mass index (>91g/m2
in males; >69 g/m2 in females) as compared to those with
normal LV mass (867 vs 857 ms; p=0.77) or in HCM
patients with substantial LGE (>10% of LV myocardium)
compared to those without LGE (860 vs 819 ms; p= 0.08).
Conclusions
In patients with HCM, noncontrast T1 mapping using
the ShMOLLI method demonstrated no significant
relationship with a variety of clinically significant HCM
clinical and imaging variables, including markers of
increased risk such as extensive LGE and extreme
hypertrophy. Although additional investigations are
necessary in larger populations, these results suggest
that T1 values may not represent a relevant clinical
marker for risk assessment in patients with HCM.
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